By API User
Dementia Australia has welcomed the publication of the results of a trial showing that a new drug, donanemab, has been able to slow the progression of symptoms of early Alzheimer’s disease. Dementia Australia CEO Maree McCabe AM said this drug was an exciting new development and another step forward in expanding the number of … Continued
By API User
CLEO DIAGNOSTICS (ASX:COV) Cleo Diagnostics (the Company) is a medical diagnostics entity focused on the development of non-invasive blood based IVD tests to detect the presence, and recurrence, of ovarian cancer. SUMMARY OF THE INITIAL PUBLIC OFFERING (IPO) Eligibility The IPO is open to: Retail, sophisticated and professional investors pursuant to a … Continued
By API User
Good afternoon, Please find attached a press release regarding the appointment of the father of India’s blood plasma industry, Dr. Ranjeet S. Ajmani, to the role of Chief Executive Officer of Aegros Asia. Aegros is an Australian technology leader in the US$20B global therapeutic plasma market. Its GMP licensed HaemaFrac® lifts process yields to over … Continued
By API User
Good afternoon, Please find attached a press release regarding the appointment of the father of India’s blood plasma industry, Dr. Ranjeet S. Ajmani, to the role of Chief Executive Officer of Aegros Asia. Aegros is an Australian technology leader in the US$20B global therapeutic plasma market. Its GMP licensed HaemaFrac® lifts process yields to over … Continued
By API User
Powered by Sanofi, a new BioMed X research team will develop a computational platform designed to accelerate drug development. HEIDELBERG, GERMANY / ACCESSWIRE / June 29, 2023 / BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation … Continued
By API User
· Significant improvement in Overall Response Rate (83%) compared with matched case control group (45%). · Significant overall survival advantage, with a 46% reduction in the risk of death. · Excellent safety profile and significant efficacy bolster HaemaLogiX’s plan to progress further KappaMab / standard of care combination studies. Sydney, June 29, 2023 – HaemaLogiX Ltd, a clinical stage Australian biotech company developing novel immunotherapies for … Continued
By API User
SAN DIEGO, CA / ACCESSWIRE / June 28, 2023 / The Oligonucleotide Therapeutics Society (OTS) is excited to bring together those in the field of oligonucleotide therapeutics for its 19th Annual Oligo Meeting. Anyone interested in oligonucleotide therapeutics is welcome to join the event, which will be held virtually and in person on Oct. 22-25, … Continued
By API User
Servatus Ltd, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, is pleased to share that its first in human Phase 1/2 clinical trial for its live biotherapeutic insomnia treatment has shown positive results. The randomized, double blinded, placebo-controlled trial was conducted at the Sleep Disorders Centre at The Prince Charles Hospital … Continued
By API User
LUXEMBOURG / ACCESSWIRE / June 26, 2023 / Moolec Science SA ((NASDAQ:MLEC) "Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today an outstanding achievement in its Meat Replacements Program for the Soybean platform, as its new "Piggy Sooy" produced a significantly high amount of … Continued
By API User
HAYWARD, CA / ACCESSWIRE / June 15, 2023 / Biolog, Inc., a leading provider of microbial polyphasic analysis, today announced the launch of the Odin™ system, an all-in-one cellular phenotyping and microbial identification platform. Odin is compatible with all Biolog assays and is available now. Until today, Biolog’s OmniLog® platform was the gold standard for … Continued
